Delivery Order SPE2DB24D1021-SPE2DB25FEXJD

Award Date 6/4/25
Potential Completion Date 6/5/25
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LAMICTAL XR 300 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $6,262.23 and a period of performance through December 13, 2023. This Delivery Order is placed under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LAMICTAL XR 25 MG TABLET 30S, with a ceiling value of $1,581.76 and a period of performance through May 30, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of LAMICTAL XR 200 MG TABLET 30S, a pharmaceutical product, with a potential value of $4,063.57 and a completion date of March 1, 2024. This delivery order is issued under a larger indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,834.90 firm fixed-price delivery order is for the supply of LAMICTAL XR 100 MG TABLET 30S. The contract has an ultimate completion date of May 10, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of LAMICTAL XR 200 MG TABLET 30S, a medical product, with an ultimate completion date of September 22, 2023 and a ceiling value of $9,992.98. The contract is a firm fixed price delivery order with no set-aside designation, indicating open...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Lamictal XR 25 mg tablets, with a ceiling value of $5,369.01 and a performance period through April 28, 2025. The contract is a firm fixed-price delivery order, and there is no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a $5,928.75 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 300 mg Lamictal XR tablets. The contract has a period of performance through July 13, 2022. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LAMICTAL XR 300 MG TABLET 30S, with a ceiling value of $4,816.85 and a period of performance ending on May 22, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Lamictal XR 250 mg tablets. The contract has a ceiling value of $4,735.62 and a period of performance through April 5, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LAMICTAL XR 100 MG TABLET 30S, with a ceiling value of $13,725.69 and a final completion date of May 16, 2025. The contract is a Firm Fixed Price agreement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB25FEXJD
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LAMICTAL XR 250 MG TABLET 30S, with a ceiling value of $2,618.76 and a performance period ending on June 5, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is not designated as a set-aside contract, indicating open competition.

Generated 9/3/25, 10:00 AM